StockVS

Zepp Health Corporation (ZEPP) Stock Analysis

Technology

Zepp Health Corporation

$8.80

+$0.18 (+2.09%)

Last Updated: May 26, 2026

Price History

Analysis

Company Overview

Zepp Health Corporation functions as a global smart wearable and health technology entity that empowers individuals to optimize their health, fitness, and wellness journeys through its consumer brands, which include Amazfit, Zepp Clarity, and Zepp Aura. The company operates within the Technology sector, specifically inside the Consumer Electronics industry, positioning it as a provider of hardware and digital solutions for personal health monitoring. As of the latest data, the company holds a market capitalization of $200.07M and reported annual revenue of $258.90M over the trailing twelve months, while the employee count is listed as N/A. These valuation and revenue figures indicate that Zepp Health maintains a mid-cap profile with a significant revenue base, suggesting a substantial operational footprint in the competitive consumer electronics landscape despite the absence of disclosed headcount metrics. The scale of the operation, evidenced by revenue approaching three-quarters of a billion dollars, underscores the company's ability to generate substantial top-line volume, even when traditional employment data is unavailable in public filings.

Financial Health

The company reported revenue of $258.90M for the trailing twelve months, yet the net income stands at a loss of $40.068M, revealing a cost structure where expenses significantly exceed operating profits before interest and taxes adjustments. EBITDA is reported at $-24.213M, indicating that the company is currently burning cash through its core operations before the impact of non-cash charges like depreciation. Free cash flow is listed as N/A, which precludes an assessment of immediate financial flexibility derived from cash generation relative to capital expenditures, though the cash on hand remains robust at $57.05M. The gross margin stands at 38.3%, suggesting that the company retains a healthy portion of revenue after direct production costs, while the operating margin of -4.5% and profit margin of -15.5% highlight the extent of overhead and non-operating expenses eroding bottom-line profitability. Regarding liquidity and leverage, the company holds $57.05M in cash against total debt of $116.31M, resulting in a debt-to-equity ratio of 54.21, which characterizes the balance sheet as leveraged rather than conservative given that debt exceeds cash reserves. The current ratio is 1.02, indicating that current assets barely cover current liabilities, suggesting a tight but functional short-term liquidity position that requires efficient working capital management. Return on Equity is -17.2% and Return on Assets is -3.3%, metrics that reveal management is currently generating negative returns on the capital invested by shareholders and utilized in assets, reflecting the challenges of the company's current growth and profitability phase.

Valuation Assessment

The trailing P/E ratio is N/A due to the lack of positive net income, while the forward P/E is listed as -1368.00, a figure that implies earnings are currently negative and makes traditional forward valuation multiples difficult to interpret in a standard sense. The price-to-book ratio is 1.01, indicating that the market values the company's equity at a level almost identical to its book value, suggesting no significant market premium or discount relative to the net asset position. Alternative valuation metrics such as the price-to-sales ratio of 0.77 and an EV/EBITDA of -143.14 provide context, showing the company trades at less than one dollar of sales and a negative enterprise value multiple due to earnings losses. The stock has exhibited significant volatility, trading between a 52-week low of $2.12 and a 52-week high of $61.85, meaning the current price sits dynamically within a range that has seen a six-fold expansion over the last year. The beta value is 1.59, which indicates that the stock's price volatility is approximately 59% higher than the broader market, reflecting high sensitivity to market movements and investor sentiment in the technology sector.

Growth & Income

Revenue growth year-over-year is 43.0%, demonstrating a robust expansion in top-line sales, whereas earnings growth is N/A because the company is currently unprofitable, meaning earnings are not growing in the traditional sense but rather moving from deeper losses toward breakeven. As a non-dividend payer, the company does not distribute a dividend yield or has a payout ratio of 0.0%, indicating that any available earnings are theoretically reinvested into growth initiatives or used to service debt rather than being distributed to shareholders. The overall growth and income profile is defined by aggressive revenue expansion coupled with a lack of current profitability and dividend distributions, characteristic of companies in the early to mid-stage of scaling operations in the consumer electronics market. This profile suggests the company prioritizes market share acquisition and product development over immediate income generation or shareholder returns via dividends.

Peer Comparison

Zepp Health Corporation (ZEPP) operates in the Consumer Electronics industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Zepp Health Corporation ZEPP $129.05M N/A
Apple Inc. AAPL.TO $5.97T 35.7
Apple Inc. AAPL $4.53T 37.3
Sony Group Corporation SONY $130.92B 20.5

The Consumer Electronics industry average P/E ratio is 128.4x. Zepp Health Corporation trades at a P/E of N/A.

This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.

About Zepp Health Corporation

Zepp Health Corporation operates as a smart wearable and health technology company worldwide. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura. The company offers smart bands, smart watches, smart rings, hearables, the Helio Strap, smart scales, and accessories; and sportswear, home appliances, and smart watch accessories. It also provides Zepp Aura, a real-time, personalized sound health solution offering health management, including emotional regulation and sports performance optimization; and provides charts and graphs to display analysis of the activity and biometric data collected from users through its Zepp Life and Zepp mobile apps. The company offers its products under the Amazfit and Zepp brand names in approximately 90 countries. The company was formerly known as Huami Corporation and changed its name to Zepp Health Corporation in February 2021. Zepp Health Corporation was founded in 2013 and is based in Gorinchem, The Netherlands.

Visit website →

Key Statistics

Market Cap
$129.05M
P/E Ratio
N/A
52-Week High
$61.85
52-Week Low
$2.25
Avg Volume
99.10K
Beta
2.02

Data provided by Yahoo Finance via yfinance. Updated daily.

Company Info

Exchange
NYSE
Country
Netherlands
Employees
763